Free Trial

RBF Capital LLC Has $2.17 Million Stake in MultiPlan Co. (NYSE:MPLN)

MultiPlan logo with Medical background

RBF Capital LLC boosted its position in shares of MultiPlan Co. (NYSE:MPLN - Free Report) by 62.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 147,051 shares of the company's stock after purchasing an additional 56,470 shares during the quarter. RBF Capital LLC owned about 0.91% of MultiPlan worth $2,173,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. XTX Topco Ltd bought a new stake in shares of MultiPlan during the fourth quarter worth approximately $225,000. Oppenheimer & Co. Inc. bought a new position in MultiPlan in the fourth quarter valued at $292,000. Walleye Capital LLC acquired a new stake in shares of MultiPlan in the fourth quarter valued at about $359,000. Renaissance Technologies LLC boosted its position in MultiPlan by 13.7% during the fourth quarter. Renaissance Technologies LLC now owns 37,415 shares of the company's stock valued at $553,000 after purchasing an additional 4,500 shares during the last quarter. Finally, Trexquant Investment LP acquired a new stake in shares of MultiPlan in the fourth quarter valued at approximately $610,000. 87.15% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Citigroup upped their target price on MultiPlan from $10.00 to $12.50 and gave the company a "neutral" rating in a research report on Friday, January 10th.

Get Our Latest Stock Report on MultiPlan

MultiPlan Price Performance

NYSE MPLN traded up $0.42 during trading on Monday, hitting $22.99. 50,864 shares of the company's stock were exchanged, compared to its average volume of 114,228. The company has a market cap of $371.77 million, a PE ratio of -0.24 and a beta of 0.13. MultiPlan Co. has a fifty-two week low of $4.80 and a fifty-two week high of $31.01. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 21.73. The stock's 50 day moving average price is $21.12 and its two-hundred day moving average price is $15.40.

MultiPlan Company Profile

(Free Report)

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.

Recommended Stories

Institutional Ownership by Quarter for MultiPlan (NYSE:MPLN)

Should You Invest $1,000 in MultiPlan Right Now?

Before you consider MultiPlan, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.

While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines